Profile data is unavailable for this security.
About the company
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
- Revenue in USD (TTM)0.00
- Net income in USD-6.91m
- Incorporated2013
- Employees3.00
- LocationGalmed Pharmaceuticals Ltd16 Tiomkin StreetTEL AVIV-YAFO 6578317IsraelISR
- Phone+972 36938448
- Fax+972 36938447
- Websitehttps://www.galmedpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60 Degrees Pharmaceuticals Inc | 253.57k | -3.99m | 2.33m | 3.00 | -- | -- | -- | 9.19 | -0.6657 | -0.6657 | 0.0456 | 0.8382 | 0.0559 | 0.9638 | 1.83 | 84,523.34 | -84.00 | -- | -- | -- | -87.15 | -- | -1,504.04 | -- | 2.39 | -1.89 | 0.0321 | -- | -50.40 | -- | 35.51 | -- | -- | -- |
Sonoma Pharmaceuticals Inc | 12.31m | -5.08m | 2.34m | 9.00 | -- | 0.3069 | -- | 0.1903 | -0.9608 | -0.9608 | 1.95 | 0.489 | 0.8625 | 2.58 | 4.76 | 1,367,778.00 | -35.56 | -37.52 | -47.14 | -51.35 | 39.17 | 40.17 | -41.23 | -37.12 | 3.11 | -- | 0.0065 | -- | 5.10 | -4.44 | -1.28 | -- | 7.54 | -- |
AgriFORCE Growing Systems Ltd | 16.28k | -11.73m | 2.35m | 7.00 | -- | 0.0709 | -- | 144.07 | -14.14 | -14.14 | 0.014 | 1.47 | 0.0008 | -- | 0.408 | 2,325.71 | -59.84 | -78.95 | -84.37 | -109.86 | 16.58 | -- | -72,071.25 | -243,182.50 | 0.6922 | -1.39 | 0.3253 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
Regen BioPharma Inc | 236.58k | -851.69k | 2.39m | 1.00 | -- | -- | -- | 10.09 | -0.2271 | -0.2271 | 0.0633 | -1.26 | 0.8644 | -- | 3.98 | 236,580.00 | -327.54 | -104.36 | -- | -- | -- | -- | -378.93 | -275.00 | -- | -1.32 | -- | -- | 0.4416 | 18.79 | -58.11 | -- | -- | -- |
Gamida Cell Ltd | 1.78m | -63.00m | 2.39m | 145.00 | -- | -- | -- | 1.34 | -0.6582 | -0.6582 | 0.0162 | -0.0204 | 0.0157 | -- | -- | 12,303.45 | -55.51 | -56.15 | -71.23 | -67.62 | 18.50 | -- | -3,531.17 | -18,390.58 | 2.09 | -- | 1.04 | -- | -- | -- | 20.63 | -- | -8.05 | -- |
Resonate Blends Inc | 16.47k | -1.42m | 2.41m | 6.00 | -- | -- | -- | 146.58 | -0.0178 | -0.0178 | 0.0002 | -0.0247 | 0.0237 | -- | -- | -- | -203.52 | -680.29 | -- | -- | -593.02 | -78.88 | -8,597.33 | -12,895.26 | -- | -0.4691 | 7.89 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
Panacea Life Sciences Holdings Inc | 2.38m | -8.02m | 2.44m | 40.00 | -- | -- | -- | 1.02 | -0.4882 | -0.4882 | 0.145 | -0.4699 | 0.1273 | 1.53 | 10.15 | 59,624.00 | -42.78 | -69.04 | -543.23 | -225.03 | -171.48 | -181.62 | -336.08 | -505.41 | 0.0331 | -2.09 | 3.29 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
cbdMD Inc | 23.45m | -23.98m | 2.45m | 52.00 | -- | 0.9091 | -- | 0.1043 | -20.34 | -20.34 | 12.19 | 0.8839 | 0.9227 | 2.06 | 23.44 | 450,876.20 | -78.62 | -38.59 | -101.68 | -41.50 | 63.84 | 63.80 | -85.21 | -87.98 | 0.6383 | -9.92 | 0.00 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
Galmed Pharmaceuticals Ltd | 0.00 | -6.91m | 2.45m | 3.00 | -- | 0.1481 | -- | -- | -3.68 | -3.68 | 0.00 | 2.75 | 0.00 | -- | -- | 0.00 | -41.65 | -45.06 | -50.55 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
Avenue Therapeutics Inc | 0.00 | -10.38m | 2.48m | 3.00 | -- | 0.9059 | -- | -- | -133.23 | -133.23 | 0.00 | 4.64 | 0.00 | -- | -- | 0.00 | -241.24 | -186.91 | -382.29 | -287.70 | -- | -- | -- | -- | -- | -70.24 | 0.00 | -- | -- | -- | -192.15 | -- | -- | -- |
SYBLEU Inc | 11.70k | -307.88k | 2.51m | -- | -- | -- | -- | 214.95 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
Virpax Pharmaceuticals Inc | 0.00 | -15.19m | 2.53m | 7.00 | -- | 1.31 | -- | -- | -12.97 | -12.97 | 0.00 | 1.65 | 0.00 | -- | -- | 0.00 | -103.68 | -87.52 | -164.09 | -116.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 29.84 | -- | -- | -- |
Qrons Inc | 0.00 | -789.36k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0581 | -0.0581 | 0.00 | -0.109 | 0.00 | -- | -- | 0.00 | -45,235.53 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -5.76 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
Marizyme Inc | 590.91k | -79.15m | 2.57m | 13.00 | -- | -- | -- | 4.34 | -1.83 | -1.83 | 0.0139 | -0.4704 | 0.0117 | 0.9575 | 12.13 | 45,454.62 | -157.28 | -29.47 | -314.26 | -30.42 | 71.63 | 67.78 | -13,393.85 | -8,518.47 | 0.025 | -0.5887 | -- | -- | 11.04 | 18.20 | -247.03 | -- | -- | -- |
American Green Inc | -100.00bn | -100.00bn | 2.57m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Data as of May 07 2024. Currency figures normalised to Galmed Pharmaceuticals Ltd's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Heights Capital Management, Inc.as of 31 Dec 2023 | 269.24k | 7.07% |
Walleye Capital LLCas of 31 Dec 2023 | 115.40k | 3.03% |
Morgan Stanley & Co. LLCas of 31 Dec 2023 | 81.23k | 2.13% |
Two Sigma Advisers LPas of 31 Dec 2023 | 44.43k | 1.17% |
Two Sigma Investments LPas of 31 Dec 2023 | 23.52k | 0.62% |
Citadel Securities LLCas of 31 Dec 2023 | 11.25k | 0.30% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 1.24k | 0.03% |
Wells Fargo Clearing Services LLCas of 31 Dec 2023 | 204.00 | 0.01% |
TSFG LLCas of 31 Mar 2024 | 200.00 | 0.01% |
Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2023 | 53.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.